ConditionsCesarean DeliveryCesarean Delivery; Neuraxial OpioidsSpinal Anesthesia for Cesarean SectionDexmedetomidineClonidinePostoperative Analgesia
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorColumbia University
About this trial
This study will examine whether addition of dexmedetomidine or clonidine (two alpha-2 adrenergic agonists) will improve the comfort of patients during spinal anesthesia for cesarean delivery. When added to standard spinal anesthesia consisting of bupivacaine (a local anesthetic) and fentanyl and morphine (two opioids), these medications may decrease some of the pulling/tugging/pressure sensations that patients sometimes feel during cesarean delivery, may prolong the anesthetic time, and may decrease postoperative pain.
Eligibility criteria
Qualifiers
Pregnant women undergoing cesarean delivery with spinal anesthesia
Disqualifiers
Significant cardiovascular, psychiatric or respiratory disease
using opioids or with chronic pain syndrome
Multiple gestation
BMI >40 kg/m2
Trial design
Treatments tested in this trial
- Clonidine
- Dexmedetomidine
Treatment groups
150 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov